Lifecore Biomedical, Inc.
LFCR
$6.18
$0.030.49%
| 11/24/2024 | 08/25/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 31.81% | -34.79% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 31.81% | -34.79% | |||
| Cost of Revenue | 11.19% | -6.29% | |||
| Gross Profit | 105.75% | -68.81% | |||
| SG&A Expenses | -12.78% | 0.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.98% | -3.46% | |||
| Operating Income | 82.88% | -414.65% | |||
| Income Before Tax | 59.84% | -127.57% | |||
| Income Tax Expenses | 272.00% | 56.14% | |||
| Earnings from Continuing Operations | 59.51% | -129.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 59.51% | -129.14% | |||
| EBIT | 82.88% | -414.65% | |||
| EBITDA | 106.90% | -252.86% | |||
| EPS Basic | 51.84% | -126.82% | |||
| Normalized Basic EPS | 60.01% | -112.51% | |||
| EPS Diluted | 52.21% | -128.55% | |||
| Normalized Diluted EPS | 60.01% | -112.51% | |||
| Average Basic Shares Outstanding | 11.36% | 1.01% | |||
| Average Diluted Shares Outstanding | 11.36% | 1.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
